Find and Join

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

• Education (and CE) from USP

  For the fourth year in a row, USP will be holding a hybrid live/virtual workshop dedicated to improving the quality of compounding. read more →

• Compounding post-Chevron

  At least three issues affecting pharmacy compounding might be affected by the overturning of the decades-old “Chevron doctrine.” read more →

• 503B sourcing: our state-by-state analysis

  Do you work for one of APC’s PFMs? If you’re with a Pharmacy/Facility Member, you’ve got access to a new resource. read more →

• What we’ll be talking about at CCH

  When we get together on Capitol Hill to meet with legislators and their staffs, as much as we’d like to talk about a half-dozen issues (easily!), we’re going to be focusing on the three most important.  read more →

More News

At CCH, you’ll hear how the organization she founded is addressing drug shortages – and equipping 503Bs

Laura Bray’s daughter Abby was undergoing chemotherapy and had developed a life-threatening allergy to one of her critical treatments. Unfortunately, the only alternative had been in drug shortage for years. The doctors told Laura there was nothing they could do.

Well, Laura tracked down the much-needed treatment in 10 days, plus two more drugs that were in shortage during Abby’s treatment.

She realized that if her family was experiencing these issues, others were, too. So, she founded Angels for Change to make sure no one else was refused access to life-saving medications due to drug shortages.

Laura is one of our speakers at this year’s CCH, joining an esteemed list that includes FDA’s OCQC Director Gail Bormel, and House Energy & Commerce Committee member Diana DeGette (D-CO).

Compounders on Capitol Hill, September 19-20, is 18 hours packed with learning and Capitol Hill advocacy, all focused on assuring your patients can access the medications they need. Join us.

Click here to register now.